The Recall Desk
SevereFDA (Devices)·Z-0185-2019·Announced 2018-10-31

Alcon Recalls CyPass Micro-Stent Due to Endothelial Cell Loss

Alcon Research is recalling CyPass Micro-Stent devices because long-term study data showed statistically significant endothelial cell loss in patients.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The agency classification is FDA Class I, which mandates a minimum severity score of 4 according to the rubric.

Plain-English summary

Alcon Research, LTD. is recalling the CyPass System 241-S, CYPASS MICRO-STENT, CYPASS LOADED, and CYPASS APPLIER (Catalog # 8065754003) for ophthalmic use. The recall affects 30,561 units distributed worldwide, including the United States, Puerto Rico, and numerous international markets.

The recall was initiated after analysis of the completed dataset from the COMPASS-XT long-term study indicated that patients in the CyPass Micro-Stent group experienced statistically significant endothelial cell loss compared to those who underwent cataract surgery alone.

Consumers and healthcare providers should contact Alcon Research for further instructions regarding the return or replacement of these devices.

The recalled product

Product
CyPass System 241-S, CYPASS MICRO-STENT, CYPASS LOADED, CYPASS APPLIER, REF CATALOG #: 8065754003 For ophthalmic use.
Affected units
30,561

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • GTIN: 00380657540037 All lot/serial numbers

Distribution

Distributed nationwide across the United States.

The notice also names 1 state specifically:

Part of a larger recall action

This product is one of 4 recalled by Alcon Research, LTD. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 4 products in this recall →

Same hazard · endothelial cell loss

See all →